Leave questions in the past.

Get answers as to why response to infliximab or adalimumab may be lost.

PROMETHEUS® Anser® ADA
is the first and only commercial test that can measure both serum adalimumab levels and antibodies to adalimumab.

Learn more 

PROMETHEUS® Anser® IFX
measures both serum infliximab levels and antibodies to infliximab.

Learn more 

NEW PROMETHEUS® Anser® UST
Simultaneously measures ustekinumab (UST) and antibodies to ustekinumab (UST) levels in serum.

Learn more 

PROMETHEUS® Anser® VDZ
uniquely measures both serum drug concentration and antibody to vedolizumab levels.


Learn more 

 

Valuable information to help guide your treatment decisions for patients who lose response to adalimumab, infliximab, infliximab biosimilar, vedolizumab, or ustekinumab.

 
©2017 Société des Produits Nestlé S.A. Vevey, Switzerland.  All rights reserved.  IFX12014  04/13
A Nestlé Health Science Company